ArticleCurrent microbiology2026
GC-MS Profiling and Protective Effects of Juglans regia Endocarp against Coccidiosis-Induced Liver Injury in Murine Model.
Article in Current microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Coccidiosis, caused by Eimeria species, is a major parasitic disease of animals that results in substantial economic losses worldwide. The increasing limitations of conventional anticoccidial drugs, including drug resistance and adverse effects, have intensified search for effective plant-derived alternatives. This study investigated anticoccidial and hepatoprotective activities of methanolic Juglans regia endocarp extract (JREE) against Eimeria papillata infection in C57BL/6 mice through parasitological, biochemical, histopathological, and oxidative stress assessments. Phytochemical profiling by gas chromatography-mass spectrometry identified 26 bioactive constituents in JREE. Thirty-five male C57BL/6 mice were randomly assigned to seven groups: negative control, non-infected JREE-treated (300 mg/kg), infected untreated, infected mice treated with JREE (100, 300, or 600 mg/kg), and infected mice treated with amprolium (120 mg/kg). Mice were orally infected with approximately 1 × 10
Indexed as
Identifiers
42732010What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.